Skip to contentK
Kyntra Bio, Inc.
K
KYNBKyntra Bio, Inc. Q3 2018 · 10-Q
Revenue$29.03M$29.03M−28.4% vs Q3 2017 Net Income-$42.56M-$42.56MN/M vs Q3 2017 EPS Diluted-$0.50-$0.50N/M vs Q3 2017 Operating Income-$42,772,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$7,101,000N/M Margins · derivedOperating margin-147.4%−91.3 pt vs Q3 2017
Net margin-146.6%−86.3 pt vs Q3 2017
ended Sep 30, 2018 · filed Nov 8, 2018 · 39 d after period end